A decade-long study which is a part of the German Ablation Registry highlighted the long-term outcomes of catheter ablation, ...

Using computers to make a digital replica of the heart—a digital heart twin—can successfully identify problem areas deep in ...

BACKGROUND: Current outcomes from catheter ablation for scar-dependent ventricular tachycardia (VT) are limited by high ...

Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, is proud to announce key milestones ...

Clinical Electrophysiology journal showed that when acute procedural success is attained in a subset of patients with ...

Headlining the year’s developments were studies of catheter ablation and concomitant use of LAAO in patients with AF.

Catheter ablation is the primary treatment option for idiopathic ventricular tachycardia (VT). It plays a key role in acute therapy of electrical storm, treatment of VTs in patients with structural ...

1.9 (p < 0.05) Change from baseline in EF: -3.4 vs. 0.3% Safety outcomes for mavacamten vs. placebo: Nonsustained ventricular tachycardia: 0% vs. 9.1% Nausea: 7.1% vs. 1.8% No patients had chronic ...

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma In this trial, patients with recurrent ...

Pulsed field ablation (PFA) could soon account for the majority of electrophysiology procedures to treat atrial fibrillation (AFib) as Medtronic, Boston Scientific and Johnson & Johnson compete in one ...

Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy characterized by high risks of sustained ventricular tachycardia (sVT) and sudden cardiac death. Identifying patients ...

Treatment options include vagal nerve stimulation, pharmacotherapy, esophageal pacing, cardioversion, and radiofrequency ablation. Inclusion criteria:Pregnant women aged between 18 and 45 ...